{"id":7631,"date":"2014-07-14T09:29:32","date_gmt":"2014-07-14T08:29:32","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=7631"},"modified":"2014-07-14T09:29:32","modified_gmt":"2014-07-14T08:29:32","slug":"actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","title":{"rendered":"Actualizaci\u00f3n del tratamiento terap\u00e9utico de la migra\u00f1a, tema principal del nuevo n\u00famero de Circular Farmac\u00e9utica"},"content":{"rendered":"<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/07\/Portada-circular.jpg\"><img decoding=\"async\" class=\"alignright  wp-image-7634\" alt=\"Portada circular\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/07\/Portada-circular.jpg\" width=\"193\" height=\"253\" \/><\/a>Ya puede leer el<strong><span style=\"text-decoration: underline; color: #888888;\"> <a href=\"http:\/\/www.cofb.org\/es\/c\/document_library\/get_file\/?uuid=2f0cde9f-be46-4edb-8072-0847d1d3c25f&amp;groupId=10136\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #888888; text-decoration: underline;\">nuevo n\u00famero de la revista cient\u00edfica del Colegio<em> Circular Farmac\u00e9utica<\/em><\/span><\/a><\/span><\/strong>, correspondiente al segundo trimestre de 2014. La edici\u00f3n de este a\u00f1o destaca la<strong>actualizaci\u00f3n del tratamiento terap\u00e9utico de la migra\u00f1a,<\/strong> considerada una enfermedad cr\u00f3nica potencialmente incapacitante.<\/p>\n<p>Al igual que en las \u00faltimas ediciones, se incluyen art\u00edculos sobre farmacoterapia, casos cl\u00ednicos y otros contenidos relacionados con los diferentes \u00e1mbitos de la farmacia.<\/p>\n<p>Le detallamos los contenidos de este n\u00famero de la revista a continuaci\u00f3n:<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Editorial:<\/strong> T. Casas\u00edn<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Farmacoterapia:<\/strong> Actualizaci\u00f3n del tratamiento terap\u00e9utico de la migra\u00f1a<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Farmacoterapia:<\/strong> El uso hospitalario de las inmunoglobulinas inespec\u00edficas intravenosas<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Espigolante<\/strong><\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Casos Cl\u00ednicos:<\/strong> Tuberculosis multirresistente en pediatr\u00eda\/ Tratamiento del paciente VIH debutante, con coinfecci\u00f3n VHB<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Alimentaci\u00f3n y Nutrici\u00f3n:<\/strong> Fichas de consejos nutricionales para distintos problemas de salud<\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Innovadores<\/strong><\/p>\n<p style=\"padding-left: 30px;\"><strong>\u2022 Vademecum Cultural<\/strong><\/p>\n<p><strong><span style=\"text-decoration: underline; color: #888888;\"><a href=\"http:\/\/www.cofb.org\/es\/web\/guest\/circular-farmaceutica\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #888888; text-decoration: underline;\">Ver n\u00fameros anteriores de<em> Circular Farmac\u00e9utica<\/em><\/span><\/a><\/span><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Ya puede leer el nuevo n\u00famero de la revista cient\u00edfica del Colegio Circular Farmac\u00e9utica, correspondiente al segundo trimestre de 2014. La edici\u00f3n de este a\u00f1o destaca la actualizaci\u00f3n del tratamiento terap\u00e9utico de la migra\u00f1a, considerada una enfermedad cr\u00f3nica potencialmente incapacitante. Al igual que en las \u00faltimas ediciones, se incluyen art\u00edculos sobre farmacoterapia, casos cl\u00ednicos y otros [\u2026]<\/p>","protected":false},"author":1,"featured_media":7634,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[32],"tags":[2149],"class_list":["post-7631","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies-farmacia","tag-publicacions"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Ja podeu llegir el nou n\u00famero de la revista cient\u00edfica del Col\u00b7legi Circular Farmac\u00e8utica, corresponent al segon trimestre de 2014. L\u2019edici\u00f3 d\u2019enguany destaca l\u2019actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, considerada una malaltia cr\u00f2nica potencialment incapacitant. Igual que ens les darreres edicions, s\u2019inclouen articles sobre farmacoter\u00e0pia, casos cl\u00ednics i altres [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-07-14T08:29:32+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica\",\"datePublished\":\"2014-07-14T08:29:32+00:00\",\"dateModified\":\"2014-07-14T08:29:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\"},\"wordCount\":167,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Publicacions\"],\"articleSection\":[\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\",\"name\":\"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-07-14T08:29:32+00:00\",\"dateModified\":\"2014-07-14T08:29:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","og_locale":"es_ES","og_type":"article","og_title":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Ja podeu llegir el nou n\u00famero de la revista cient\u00edfica del Col\u00b7legi Circular Farmac\u00e8utica, corresponent al segon trimestre de 2014. L\u2019edici\u00f3 d\u2019enguany destaca l\u2019actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, considerada una malaltia cr\u00f2nica potencialment incapacitant. Igual que ens les darreres edicions, s\u2019inclouen articles sobre farmacoter\u00e0pia, casos cl\u00ednics i altres [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-07-14T08:29:32+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica","datePublished":"2014-07-14T08:29:32+00:00","dateModified":"2014-07-14T08:29:32+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/"},"wordCount":167,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"thumbnailUrl":"","keywords":["Publicacions"],"articleSection":["Not\u00edcies farm\u00e0cia"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","url":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/","name":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-07-14T08:29:32+00:00","dateModified":"2014-07-14T08:29:32+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/07\/14\/actualitzacio-del-tractament-terapeutic-de-la-migranya-tema-principal-del-nou-numero-de-circular-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, tema principal del nou n\u00famero de Circular Farmac\u00e8utica"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Ja podeu llegir el nou n\u00famero de la revista cient\u00edfica del Col\u00b7legi Circular Farmac\u00e8utica, corresponent al segon trimestre de 2014. L\u2019edici\u00f3 d\u2019enguany destaca l\u2019actualitzaci\u00f3 del tractament terap\u00e8utic de la migranya, considerada una malaltia cr\u00f2nica potencialment incapacitant. Igual que ens les darreres edicions, s\u2019inclouen articles sobre farmacoter\u00e0pia, casos cl\u00ednics i altres [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/7631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=7631"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/7631\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=7631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=7631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=7631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}